TIAA FSB’s Vertex Pharmaceuticals VRTX Stock Holding History

TIAA FSB’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$1.84M	Buy	5,227 +77	+1%	+$25.9K	0.01%	261
2023 Q1	$1.62M	Sell	5,150 -255	-5%	-$76.5K	0.01%	264
2022 Q4	$1.56M	Buy	5,405 +303	+6%	+$92.3K	0.01%	261
2022 Q3	$1.48M	Sell	5,102 -372	-7%	-$107K	0.01%	259
2022 Q2	$1.54M	Buy	+5,474	New	+$1.47M	0.01%	265
2019 Q4	–	Sell	-36,118	Closed	-$6.12M	–	305
2019 Q3	$6.12M	Sell	36,118 -41,307	-53%	-$7.31M	0.03%	159
2019 Q2	$14.2M	Buy	77,425 +28,424	+58%	+$4.97M	0.08%	97
2019 Q1	$9.01M	Buy	49,001 +2,199	+5%	+$406K	0.07%	119
2018 Q4	$7.76M	Buy	46,802 +2,478	+6%	+$429K	0.04%	123
2018 Q3	$8.54M	Buy	44,324 +3,983	+10%	+$709K	0.04%	121
2018 Q2	$6.86M	Buy	+40,341	New	+$6.25M	0.04%	133

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TIAA FSB's VRTX Position: Q2 2023 in Review

TIAA FSB increased its Vertex Pharmaceuticals (VRTX) stake by 1.5% in Q2 2023, buying an estimated $25.9K and bringing the position to 5,227 shares worth $1.84M. The position accounts for 0.01% of the portfolio, ranked #261.

TIAA FSB first reported a position in VRTX in Q2 2018 and has held it in 11 quarters since. The position peaked at $14.2M in Q2 2019. 1,285 funds tracked by Wall St. Rank hold VRTX as of Q2 2023.

TIAA FSB held 5,227 shares of Vertex Pharmaceuticals worth $1.84M as of Q2 2023.
TIAA FSB bought 77 Vertex Pharmaceuticals shares in Q2 2023, an estimated $25.9K.
Vertex Pharmaceuticals made up 0.01% of TIAA FSB's portfolio in Q2 2023, its #261 holding.
TIAA FSB first reported a position in Vertex Pharmaceuticals in Q2 2018 and has held it in 11 quarters since.
TIAA FSB's Vertex Pharmaceuticals position peaked at $14.2M in Q2 2019.
1,285 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2023.

Based on TIAA FSB's 13F filing for Q2 2023, filed 31 Jul 2023.